Predictors and outcomes of acute recoil after ultrathin bioresorbable polymer sirolimus-eluting stents implantation: an intravascular ultrasound in native coronary arteries

Coron Artery Dis. 2022 Jan 1;31(1):18-24. doi: 10.1097/MCA.0000000000001067.

Abstract

Background: Ultrathin bioresorbable polymer sirolimus-eluting stents (BP-SESs) may easily lead to acute recoil. This study investigated acute recoil after BP-SES implantation on the basis of intravascular ultrasound (IVUS).

Methods: We enrolled 40 consecutive stents. Absolute acute recoil by quantitative coronary angiography was defined as the difference between the mean diameter of the last inflated balloon (X) and mean lumen diameter of the BP-SES immediately after balloon deflation (Y). Percent (%) acute recoil was defined as (X-Y)×100/X. IVUS was performed within the culprit lesion. Plaque eccentricity, % plaque burden and calcification grade score were assessed using IVUS. Calcification grade was scored on the basis of quadrants. On the basis of the median acute recoil value of 5.0%, the stents were divided into two groups: low (LAR, n = 20) and high % acute recoil (HAR, n = 20).

Results: Mean % acute recoil was 5.8 ± 5.3%. Plaque eccentricity, % plaque burden and stent/artery ratio were significantly higher in the HAR group than in the LAR group. Significant differences in % acute recoil were not observed regarding the types of stent diameter. In multivariate logistic regression and multiple linear regression analysis, plaque eccentricity and % plaque burden in the culprit plaque were significant positive predictors for the occurrence of % acute recoil. No significant differences, including clinical outcomes, were found between both groups at follow-up.

Conclusion: Acute recoil of BP-SESs may be influenced by an eccentric plaque with a large burden, which did not affect long-term outcomes. However, the present study might suggest the proper strategy (e.g. a more exhaustive plaque preparation) before BP-SES implantation in a case with these IVUS characteristics.

MeSH terms

  • Absorbable Implants / standards
  • Absorbable Implants / statistics & numerical data
  • Aged
  • Aged, 80 and over
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / surgery
  • Coronary Vessels / physiopathology
  • Coronary Vessels / surgery*
  • Drug-Eluting Stents / standards*
  • Drug-Eluting Stents / statistics & numerical data
  • Female
  • Humans
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care / methods
  • Outcome Assessment, Health Care / statistics & numerical data
  • Sirolimus / pharmacology
  • Sirolimus / therapeutic use
  • Ultrasonography, Interventional / methods
  • Ultrasonography, Interventional / statistics & numerical data

Substances

  • Sirolimus